Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

13.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.8K
Energy to Drive Translocation01:37

Energy to Drive Translocation

3.0K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
3.0K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

375
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
375
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

329
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
329
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

369
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
369
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

549
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
549

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magazine.

International maritime health·2026
Same journal

Characteristics of disease patterns in tuna fishermen.

International maritime health·2026
Same journal

Characteristics of Polish travellers admitted at the University Centre of Maritime and Tropical Medicine in Poland, 2024-2025.

International maritime health·2026
Same journal

Oral and perioral disease prevalence among fishermen - systematic review and meta-analysis.

International maritime health·2026
Same journal

Musculoskeletal disorders and associated factors among fishermen in Vietnam - a cross-sectional study.

International maritime health·2026
Same journal

Occupational health and safety compliance in Turkish fishing vessels: a regulatory assessment.

International maritime health·2026
Same journal

A 4-year retrospective descriptive study on treatment outcomes of decompression illness patients in various hyperbaric chamber centers in Thailand.

International maritime health·2026
See all related articles
  1. Home
  2. Magazine 2026/1: Special Edition - Medical Repatriation And Tmas.
  1. Home
  2. Magazine 2026/1: Special Edition - Medical Repatriation And Tmas.

Related Experiment Video

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

23.1K

Magazine 2026/1: Special Edition - Medical Repatriation and TMAS.

James Denham Editor1

  • 1jdenhammd@hotmail.com.

International Maritime Health
|March 31, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Deciding to medically repatriate a seafarer involves complex medical judgment, balancing onboard resources and patient well-being. Maritime Telemedical Assistance Services (TMAS) are crucial for guiding these decisions for seafarers at sea.

Keywords:
TMASaccess to carefitness to travelmaritime medicinemedical decision-makingoperational constraintsremote carerepatriationseafarerstelemedicine

More Related Videos

Repetitive Transcranial Magnetic Stimulation to the Unilateral Hemisphere of Rat Brain
05:47

Repetitive Transcranial Magnetic Stimulation to the Unilateral Hemisphere of Rat Brain

Published on: October 22, 2016

13.1K
Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships
06:05

Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships

Published on: April 20, 2022

2.4K

Related Experiment Videos

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

23.1K
Repetitive Transcranial Magnetic Stimulation to the Unilateral Hemisphere of Rat Brain
05:47

Repetitive Transcranial Magnetic Stimulation to the Unilateral Hemisphere of Rat Brain

Published on: October 22, 2016

13.1K
Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships
06:05

Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships

Published on: April 20, 2022

2.4K

Area of Science:

  • Maritime Medicine
  • Telemedicine
  • Public Health

Background:

  • Medical repatriation for seafarers is a complex decision influenced by limited onboard resources and operational constraints.
  • The Maritime Labour Convention (MLC 2006) mandates appropriate medical care and repatriation for seafarers facing illness or injury at sea.
  • Telemedical Assistance Services (TMAS) play a vital role in supporting medical decision-making for seafarers globally.